Nazia Selzner

Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion.

Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy.

Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis.

Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: A TNF-alpha/IL-6-dependent mechanism.

Living donor liver transplantation in patients with portal vein thrombosis: a survey and review of technical issues.

ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice.

Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism.

Protective strategies against ischemic injury of the liver.

Liver regeneration after adult living donor and deceased donor split-liver transplants.

Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.

Increased ischemic injury in old mouse liver: an ATP-dependent mechanism.

Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients.

Can genetic variations predict HCV treatment outcomes?

The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.

The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.

Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.

Live donor liver transplantation in high MELD score recipients.

Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age.

Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection.

The immunosuppressive pipeline: meeting unmet needs in liver transplantation.

Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients.

FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice.

Preconditioning, postconditioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications.

Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.

Role of regulatory T cells in the promotion of transplant tolerance.

Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.

Serum aspartate aminotransferase levels and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis C.

The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection.

Measurements of serial plasma levels of albumin mRNA for management of patients post transplant: does it add value?

Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.

One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantation.

Enteral Energy and Macronutrients in End-Stage Liver Disease.

Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.

Subnormothermic ex vivo liver perfusion reduces endothelial cell and bile duct injury after donation after cardiac death pig liver transplantation.

Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubation.

Recipient factors associated with having a potential live liver donor.